Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Koslowski M et al. – This is the first report establishing CDX2 as transactivator of tumor growth–promoting gene expression in colon cancer, adding to untangle the complex and conflicting biological functions of CDX2 in colon cancer and supporting MS4A12 as important factor for normal colonic development as well as for the biology and treatment of colon cancer.

Related Articles

Unusual Metals Could Forge New Cancer Drug
ScienceDaily, 10/20/09    Relevance Score: 70%

Management of Primary Colon Cancer in Older Adults
Geriatrics & Aging, 10/12/09    Relevance Score: 70%

Estimated dose to the rectum and colon in prostate cancer patients treated with exclusive radiation therapy presenting a secondary colorectal malignancy
Clinical Oncology, 10/07/09    Relevance Score: 70%

Oncogenic KRAS and BRAF Differentially Regulate Hypoxia-Inducible Factor-1alpha and -2alpha in Colon Cancer
Cancer Research, 11/03/09    Relevance Score: 69%

Plasma enterolactone and risk of colon and rectal cancer in a case–cohort study of Danish men and women
Cancer Causes and Control, 10/28/09    Relevance Score: 69%

Today in Basic Science/Genetics...keeping you current

Co-expression of plexin-B1 and Met in human breast and ovary tumours enhances the risk of progression
Cellular Oncology, 12/07/09

Prognostic relevance of promoter hypermethylation of multiple genes in breast cancer patients
Cellular Oncology, 12/07/09

Differential apoptotic response of human cancer cells to organoselenium compounds
Cancer Chemotherapy and Pharmacology, 12/07/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address